HomeBiotechnology

Biotechnology Market Research Reports & Consulting

discount on Mnm

Market Reports


Title Published Price TOC Available

European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020

The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.

July 2015 $ 5650 selected

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

The neuromodulation market is segmented on the basis of technology, application, and region. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players, and expanded target applications and new indications are driving the growth of this market. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the neuromodulation market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals act as restraints hindering its market growth.

July 2015 $ 5650 selected

Aptamers Market by Type (DNA, RNA, XNA), Application (Diagnostics, Therapeutics, R&D), Technology (SELEX, Other Technologies) & by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020

The global aptamers market is expected to reach $244.93 Million by 2020 from $107.56 Million in 2015, at a CAGR of 17.89%. Aptamers bind to target protein, lipid, or nucleic acid molecules with a high degree of specificity. Aptamers can be generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. These can be used as pharmaceutical leads, detection reagents, and functional proteomic levels (with small molecules, antibodies, or other aptamers). The scope of this market report includes DNA-, RNA-, and XNA-based aptamers used for research applications.

June 2015 $ 5650 selected

Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020

The expression vectors market is expected to reach $317.1 Million by 2020 from $242.7 Million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. Major factors driving the growth of this market include the increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. On the other hand, high market consolidation, which increases entry barriers, and high cost of protein therapy are the major factors restraining the growth of this market.

June 2015 $ 5650 selected

Oxidative Stress Assay Market by Product (Consumables, Instruments, Services), Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), Technology (ELISA, Chromatography, Flow Cytometry), End Users - Global Forecast to 2020

The global oxidative stress assays market is expected to reach $736.85 Million by 2020 from $452.36 Million in 2015, at a CAGR of 10.25% between 2015 and 2020. Factors such as rapid growth in the biopharmaceutical industry, strong trend of R&D investments in biotechnology and pharmaceutical industries, technological advancements like high-content screening for drug discovery, and government funding for life science research are driving the growth of the oxidative stress assays market. On the other hand, high cost of instruments and dearth of trained manpower for new and emerging technologies are the major factors restraining the growth of this market.

May 2015 $ 5650 selected

Protein Purification & Isolation Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, Ion Exchange & Affinity Chromatography) by Product (Instruments, Kits, Reagents, Resins) by Application & End User - Global Forecast to 2020

Protein purification is a process for isolation of one or a more proteins from a complex mixture, usually consisting of cells or tissues. Protein purification is a necessary step in any protein study, and is performed after measuring the enzyme activity of the given sample through assay processes to confirm the presence of a protein or proteins of interest. The Global Protein Purification and Isolation Market Is Expected to Reach $11 Billion to $12 Billion by 2020

April 2015 $ 5650 selected

Live Cell Imaging Market by Product (Equipment, Consumables, Software), Technology (Fluorescence Recovery after Photobleaching, High-Content Screening) & by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019

The live cell imaging market is segmented on the basis of products, technologies, applications, and regions. The global live cell imaging market was valued at $3.57 Billion in 2014 and is poised to grow at a CAGR of 8.8% during the forecasted period. Some of the major players in the global live cell imaging market include Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc.(U.S.).

April 2015 $ 5650 selected

Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019

The global molecular weight marker market was valued at $265.36 million in 2014 and is poised to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019. Increased research and development spending by biotechnology and pharmaceutical companies, increasing public funding for life science research, and new innovations in genomics and proteomics research will drive the growth of the molecular weight markers market.

February 2015 $ 5650 selected

Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectroscopy), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery & Development), & by End Users - Global Forecast to 2019

The global protein characterization and identification market was valued at $1,569.00 million in 2014, and is expected to grow at a CAGR of 10.63% to reach $2,600.28 million in 2019. Protein characterization and identificationinstruments and consumables find applications in a large number of fields in life science research, as well as clinical diagnosis and drug discovery and development. Protein characterization and identificationproducts are widely used for the biomarker identification applications and characterization of biopharmaceuticals.Being one of the most widely-used applications of protein characterization, drug discovery and development was one of the largest application segments of the global protein characterization and identification market in 2014.

October 2014 $ 5650 selected

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

The global transcriptomics market was valued at $1,743.2 million in 2013 and is expected to reach at $3,773.0 million by 2019, at a CAGR of 13.7% during the forecast period of 2014 to 2019. This market is mainly driven by the increasingtechnological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyze enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent

September 2014 $ 5650 selected

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

September 2014 $ 5650 selected

Chiral Chromatography Column Market by type (Empty, Pre-packed, Analytical, Preparative), Material (Metal, Glass, Plastic), & by Application [GC, LC (HPLC, UHPLC, Flash Chromatoraphy, UFLC), TLC,SFC] - Forecast to 2018

The chiral chromatography column market is segmented on the basis of columns, materials, applications, end users, and geography.The chiral chromatography columnsmarket comprisesof two types of columns empty and pre-packed columns. The pre-packed columns are further categorized into analytical columns and preparative columns. The chiral chromatographycolumnsmarket size was $68 million in 2013 and is expected to reach $87.8 million by 2018, at a CAGR of 5.2%.

September 2014 $ 5650 selected

Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], Services (Sequencing), Technology (Sequencing by Synthesis), & by Application (Cancer, Monogenic disorders) - Global Forecast to 2018

This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S.

August 2014 $ 5650 selected

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

The global isothermal nucleic acid technology (INAAT) market is estimated to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. The market growth is primarily attributed to increasing demand for advanced isothermal based molecular testing over conventional thermal polymerase chain reaction (PCR) technology.

May 2014 $ 5650 selected

Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) - Forecast to 2018

The future growth prospects for the protein crystallization & crystallography market are optimistic and it is estimated to grow at a CAGR of 10.1% to reach a worldwide market of $1,253 million by 2018. The increasing use of crystallization for membrane protein structure elucidation, increasing R&D by big pharmaceutical and biotechnology firms, technological advancements, and increasing government funding are all factors that are expected to fuel the growth of the protein crystallization & crystallography market in the near future. However, insufficiency of qualified and experienced researchers, lack of generalized crystallization methods associated with the types of proteins, and highly time-consuming and expensive protein crystallization and crystallography processes are expected to hinder the growth of this market during the forecasted period. The key unmet market needs provide huge opportunities for both, the key players and new entrants in this industry.

February 2014 $ 5650 selected

Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018

The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.

August 2013 $ 5650 selected

European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.

June 2013 $ 5650 selected

North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017

The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.

April 2013 $ 5650 selected

Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017)

Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends.

December 2012 $ 5650 selected

Biotechnology Reagents Market by Technology (PCR, Cell Culture, Expression & Transfection, Chromatography, Mass Spectrometry, Electrophoresis, & Flow Cytometry), Applications (Protein Purification, Gene Expression, DNA & RNA Analysis, & Drug Testing) and End-Users - Current Trends, Opportunities and Global Forecasts to 2016

Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education.

July 2012 $ 5650 selected

Life Sciences & Analytical Reagents Market - Applications, Current Trends, Opportunities & Global Forecasts (2011 – 2016)

The life sciences and analytical reagents market report studies the life science and analytical reagents market, by technology, end-users, and applications. The life sciences and analytical reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011.

May 2012 $ 5650 selected

Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)

The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.

May 2011 $ 5650 selected

Brazil Biomaterials Market (2010-2015)

Brazil Biomaterials Market is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.

May 2011 $ 5650 selected

Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015

This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.

February 2011 $ 5650 selected

Strategic Analysis & Forecast of US Biopharmaceutical Industry – (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market

The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.

February 2011 $ 5650 selected

Top 10 Drug Discovery Technologies Market – Strategic Analysis and Global Forecasts (2010 to 2015)

The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies.

November 2010 $ 5650 selected



4 >> >

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us


Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support



US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment.
'Connect With Us

Call us at: 1-888-600-6441
Live Chat Support


Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo